(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Top notch DSLR Cameras for Photography Devotees - 2I'm a woman who's into weightlifting. Was I man enough for the creatine-packed 'Man Cereal'?
- 3The most effective method to Connect Successfully with Teachers in a Web based Setting
- 4High Court freezes government move to shutter Army Radio pending ruling
- 5Beneficial Growing Conditions in West Africa Weigh on Cocoa Prices
- Two Indonesian UN peacekeepers killed in explosion in Lebanon
- Obamacare enrollment declines as US subsidies expire
- Hundreds rally in West Bank against Israeli death penalty for Palestinians
- True serenity: Investigating Emotional well-being and the Advantages of Contemplation
- Fetterman says he's back home after a fall put the Pennsylvania senator in the hospital
- Interoceanic Train derails in southern Mexico, injuring at least 15 and halting traffic on line
- Iran warns its ready to open new front in Yemen, close Bab al-Mandab Strait with Houthis
- World's oldest known tortoise still very much alive despite rumor to the contrary
- Two policemen injured at religious youth protest in Jerusalem marking Ahuvia Sandak's death
